UNC2541 is primarily utilized in biochemical and pharmacological research as a selective inhibitor. It targets specific enzymes or proteins involved in cellular signaling pathways, making it a valuable tool for studying the mechanisms of these pathways. Researchers use UNC2541 to investigate the role of certain kinases or receptors in disease processes, particularly in cancer and inflammatory conditions. Its application helps in understanding the potential therapeutic effects of modulating these targets, contributing to the development of novel drug candidates. Additionally, UNC2541 is employed in high-throughput screening assays to identify and validate new drug targets, aiding in the discovery of more effective treatments for various diseases.